Nutritional supplement market growing

Article

The eyecare nutritional supplement market is worth $43.4 million and is projected to grow to $87.4 million within five years, according to research by Frost & Sullivan.

The eyecare nutritional supplement market is worth $43.4 million and is projected to grow to $87.4 million within five years, according to research by Frost & Sullivan.

According to Frost & Sullivan, the impending rapid growth in the market is due to the ageing of the "baby boomer" generation, as well as the recent developments in nutritional supplements for conditions commonly associated with either lifestyle or advanced age, including glaucoma and age-related macular degeneration.

Although nutritional supplements for eye conditions are a relatively new concept, the products Frost & Sullivan assessed included antioxidants such as lutein, beta-carotene, zeaxanthin, astaxanthin, and bilberry.

Despite barriers such as increasing price erosion and variation in international regulations, increased consumer awareness and more validated research into nutritional supplements' efficacy will result in great potential for growth in the market, Frost & Sullivan concluded.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.